Related Experiment Video

Updated: May 29, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes

Yi-Bing Ouyang1, Yu Lu, Sibiao Yue

  • 1Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA. ybouyang@stanford.edu

Mitochondrion
|October 1, 2011
PubMed

Insights

MicroRNA-181 (miR-181) regulates apoptosis by targeting Bcl-2 family proteins in brain cells. Lower miR-181 levels protect astrocytes from cell death and mitochondrial damage.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Mitochondria play a critical role in apoptosis.
  • The Bcl-2 protein family regulates apoptosis by interacting with mitochondria.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.

Purpose of the Study:

  • To investigate the role of miR-181 in regulating Bcl-2 family proteins.
  • To determine the effect of miR-181 on apoptosis and mitochondrial function in astrocytes.

Main Methods:

  • Bioinformatic prediction of miR-181 targets within Bcl-2 family 3'UTRs.
  • Luciferase reporter assays to confirm miRNA-target interactions.
  • Manipulation of miR-181 levels using mimics and inhibitors in primary astrocyte cultures.

Main Results:

  • miR-181 was predicted and confirmed to target Bcl-2-L11/Bim, Mcl-1, and Bcl-2.
  • Reduced miR-181 levels led to increased Bcl-2 and Mcl-1 protein expression.
  • Decreased miR-181 levels attenuated glucose deprivation-induced apoptosis, mitochondrial dysfunction, and loss of mitochondrial membrane potential.

Conclusions:

  • miR-181a directly targets and regulates key Bcl-2 family members.
  • miR-181a plays a protective role in astrocytes against apoptosis and mitochondrial dysfunction.
  • miR-181 represents a potential therapeutic target for conditions involving astrocyte death.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...